Cresco Labs OTC (CRLBF)
OTHER OTC:CRLBF
Earnings Data
Report Date
Aug 06, 2026Before Open (Not Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.04Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.Company Guidance
Quarterly Revenue and Profitability
Q1 2026 revenue of $151.0 million, adjusted gross profit of $77.0 million, adjusted gross margin of 51%, and adjusted EBITDA of $33.0 million (22% of revenue).
Strong Retail Unit Economics
Sunnyside dispensaries generate over 30% more revenue per store than state averages, sustained outperformance over multiple quarters despite competition and pricing pressure.
Balance Sheet and Liquidity
Ended Q1 with $67.0 million in cash and restricted cash, providing capital to pursue growth opportunities and to fund Phase 1 of Kentucky build-out.
Growth-by-Execution: Store Expansion and M&A
Year-to-date added 11 dispensaries (9 in Pennsylvania via an MSA and 2 in Ohio). Pennsylvania footprint expands to 27 stores (18 existing + 9 acquired/operated under MSA) and the PA transaction is structured as accretive subject to regulatory close.
Market Entry and Licensing Wins
Received 1 of only 15 Merit-based licenses in Texas and achieved successful license application(s) and first harvest in Kentucky (first harvest in April), with branded products expected to reach patients in Q2.
Operational Improvements in Cultivation and Wholesale
Improved yields and product quality: average flower potency up materially year-over-year and higher yields from the same assets, supporting wholesale leadership in Illinois, Pennsylvania, Massachusetts and Ohio and helping maintain share in Florida despite new competitor capacity.
Q2 Forward Guidance
Company expects Q2 revenue to increase approximately 10% sequentially; forecasts gross margins between 48%–50% and adjusted EBITDA margins near 21%, reflecting operational improvements offsetting pricing pressure.
Capital Allocation and Investment
Invested $11.0 million in capital expenditures and acquisitions in Q1 (majority to Kentucky Phase 1). Management describes M&A as accretive with expected incremental revenue and cost synergies as integration progresses.
CRLBF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CRLBF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2026 | $1.10 | $1.03 | -6.36% |
Mar 05, 2026 | $0.97 | $0.93 | -4.62% |
Nov 05, 2025 | $1.07 | $1.08 | +0.93% |
Aug 07, 2025 | $0.69 | $0.68 | -1.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cresco Labs OTC (CRLBF) report earnings?
Cresco Labs OTC (CRLBF) is schdueled to report earning on Aug 06, 2026, Before Open (Not Confirmed).
What is Cresco Labs OTC (CRLBF) earnings time?
Cresco Labs OTC (CRLBF) earnings time is at Aug 06, 2026, Before Open (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CRLBF EPS forecast?
CRLBF EPS forecast for the fiscal quarter 2026 (Q2) is -0.02.